Romidepsin Enhances the Efficacy of Cytarabine in Vivo, Revealing Histone Deacetylase Inhibition as a Promising Therapeutic Strategy for KMT2A-rearranged Infant Acute Lymphoblastic Leukemia
Haematologica - Italy
doi 10.3324/haematol.2018.192906
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 24, 2019
Authors
Publisher
Ferrata Storti Foundation (Haematologica)